DM
FLGT icon

Deerfield Management’s Fulgent Genetics FLGT Stock Holding History

Deerfield Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-21,690
Closed -$471K – 227
2024
Q3 		$471K Buy
+21,690
New +$485K 0.01% 298
2024
Q2 		– Sell
-10,959
Closed -$238K – 486
2024
Q1 		$238K Buy
10,959
+1,130
+11% +$28.1K ﹤0.01% 303
2023
Q4 		$284K Buy
+9,829
New +$263K 0.01% 129

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deerfield Management's FLGT Position: Q4 2024 in Review

Deerfield Management sold out of Fulgent Genetics (FLGT) in Q4 2024, closing a stake of 21,690 shares — an estimated $471K sold.

Deerfield Management first reported a position in FLGT in Q4 2023 and held it in 3 quarters. The position peaked at $471K in Q3 2024. 189 funds tracked by Wall St. Rank hold FLGT as of Q4 2024.

  • Deerfield Management reported no remaining Fulgent Genetics position as of Q4 2024 after selling out during the quarter.
  • Deerfield Management sold 21,690 Fulgent Genetics shares in Q4 2024, an estimated $471K.
  • Deerfield Management first reported a position in Fulgent Genetics in Q4 2023 and held it in 3 quarters.
  • Deerfield Management's Fulgent Genetics position peaked at $471K in Q3 2024.
  • 189 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2024.

Based on Deerfield Management's 13F filing for Q4 2024, filed 14 Feb 2025.